Bookmarks
Granular ICU data focussing on the impact of lactate readings on outcomes
Population Size
12,369
People
Years
2018 - 2020
Associated BioSamples
None/not available
Geographic coverage
United Kingdom
England
Lead time
1-2 months
Summary
Documentation
Lactate is a chemical produced by the body as cells consume energy - in times of stress more lactate is produced. In the past, we thought that lactate was just a waste product, but more recently we have learned that lactate has an important role to play in the body.
People suffering from certain severe illnesses may have a high ‘lactate’ level in their blood. This is particularly common in the following:
Severe infections which the body cannot properly control (sepsis)
People who have sustained severe injuries (traumatic injury)
People who are critically unwell with other illnesses (needing treatment in an intensive care unit)
Some patients will develop a high lactate level when they are in hospital. Doctors recognise that this indicates the patient is becoming more unwell, but it is often challenging to know exactly what is causing the lactate level to be raised.
Raised lactate level has been associated with worse outcome in other syndromes, including major trauma and undifferentiated critical illness; however healthy individuals may generate very high lactate levels during strenuous exercise from which they recover without any harm. It is unclear whether lactate in itself is harmful to patients. This dataset provides unique insight into the potential role of lactate as not only a biomarker but a therapeutic target in acute illness.
PIONEER geography The West Midlands (WM) has a population of 5.9 million and includes a diverse ethnic and socio-economic mix.
EHR. UHB is one of the largest NHS Trusts in England, providing direct acute services and specialist care across four hospital sites, with 2.2 million patient episodes per year, 2750 beds and an expanded 250 ITU bed capacity during COVID. UHB runs a fully electronic healthcare record (EHR) (PICS; Birmingham Systems), a shared primary and secondary care record (Your Care Connected) and a patient portal “My Health”.
Scope: Longitudinal and individually linked, so that the preceding and subsequent health journey can be mapped and healthcare utilisation prior to and after admission understood. The dataset includes highly granular patient demographics, co-morbidities taken from ICD-10 and SNOMED-CT codes. Serial, structured data pertaining to process of care (timings, admissions, wards), presenting complaint, physiology readings (BMI, temperature and weight), Sample analysis results (blood sodium level, lactate, haemoglobin, oxygen saturations, and others) drug administered and all outcomes.
Available supplementary data: Matched controls; ambulance, OMOP data, synthetic data.
Available supplementary support: Analytics, Model build, validation & refinement; A.I.; Data partner support for ETL (extract, transform and load) process, Clinical expertise, Patient and end-user access, Purchaser access, Regulatory requirements, Data-driven trials, “fast screen” services.
Dataset type
Dataset sub-type
Dataset population size
Keywords
Observations
Observed Node | Disambiguating Description | Measured Value | Measured Property | Observation Date |
---|---|---|---|---|
Persons | 12,369 ICU admissions with lactate reading from 01/01/2018 to 31/12/2020 | 12369 | Count | 25 Nov 2021 |
Provenance
Purpose of dataset collection
Source of data extraction
Collection source setting
Patient pathway description
Image contrast
Biological sample availability
Structural Metadata
Details
Publishing frequency
Version
Modified
08/10/2024
Distribution release date
25/11/2021
Citation Requirements
Coverage
Start date
01/01/2018
End date
28/12/2020
Time lag
Geographic coverage
Minimum age range
Maximum age range
Follow-up
Accessibility
Language
Alignment with standardised data models
Controlled vocabulary
Format
Data Access Request
Dataset pipeline status
Time to dataset access
Access request cost
Access method category
Access service description
Trusted Research Environments (TRE) are built using Microsoft Azure services and hosted in the UK to provide research teams a safe, secure and agile environment which allows users to quickly analyse, interpret and form an enriched view of primary care information through a range of integrated datasets.
Health data collated from multiple sources is ingested into a secure data lake which will then allow subsets of data to be made available to research teams on approval of a data request. Once approved a customer specific TRE is made available with a standard set of leading analytical tools from Microsoft including Azure Databricks, Azure Machine Learning, Azure SQL and Azure Synapse (for large-scale data warehouses). Specific tools can be provided at an additional cost over the standard platform data access charge and the PIONEER team will work with you to determine your exact needs.
Access to the TRE is managed using the latest virtual desktop technology to provide a safe and secure end-user experience. By utilising leading edge design PIONEER are able to create TREs rapidly to enable us to service any customer requirement.
Jurisdiction
Data use limitation
Data use requirements
Data Controller